Treatment Characteristics and Outcomes of Patients With Chronic/Small Lymphocytic Leukemia (CLL) Treated With Venetoclax and Bruton Tyrosine Kinase Inhibitor (BTKi) Combination Therapies

Tuncer, Hande H. ; Ghosh, Nilanjan ; Fleury, Isabelle ; Leslie, Lori A. ; Manzoor, Beenish S. ; Lamanna, Nicole ; Eyre, Toby A. ; Hill, Brian T. ; Brown, Jennifer R. ; Sinai, Wendy ; Coombs, Catherine C. ; Ujjani, Chaitra ; Roeker, Lindsey E. ; Emechebe, Nnadozie ; Barr, Paul M. ; Davids, Matthew S. ; Martinez-Calle, Nicolas ; Rhodes, Joanna M. ; Lansigan, Frederick ; Pearson, Laurie ; Choi, Yun ; Schuster, Stephen J. ; Skarbnik, Alan P. ; Fakhri, Bita ; Coyle, Michael ; Stephens, Deborah M. ; Thompson, Meghan C. ; Jensen, Christopher E. ; Marx, Steven E. ; Jawaid, Dureshahwar ; Schuh, Anna ; Pivneva, Irina ; Watson, Talissa ; Guerin, Annie ; Shadman, Mazyar

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S183-S183 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível